Literature DB >> 15198502

Pharmacokinetics of the time-dependent elimination of all-trans-retinoic acid in rats.

Anas Saadeddin1, Francisca Torres-Molina, Jaime Cárcel-Trullols, Amparo Araico, José-Esteban Peris.   

Abstract

The time-dependent elimination kinetics of all-trans-retinoic acid (ATRA) has been associated with autoinduction of its metabolism and has led to the hypothesis that rapid development of acquired clinical resistance to ATRA may be prevented by coadministration of metabolic inhibitors. This study in rats was performed to investigate the pharmacokinetics and onset of time-dependent elimination of ATRA, with the purpose of establishing an animal model suitable for in vivo preclinical studies of compounds capable of inhibiting ATRA metabolism. After the intravenous (IV) bolus administration of single doses of ATRA (1.60 mg kg(-1) and 0.40 mg kg(-1)), the plasma concentration-time curves showed an accelerated decline at 180 minutes after dosing. The plasma clearance (Cl) of ATRA, determined after IV administration of a second dose (1.60 mg kg(-1)), at 180 minutes was greater than Cl after a single dose, thus indicating the existence of a time-dependent elimination process detectable 180 minutes after administration of the first dose. Such time-dependent elimination was confirmed by means of an IV constant-rate infusion of 0.48 mg h(-1) kg(-1) of ATRA during 10 hours. Peak plasma ATRA concentration was achieved at 180 minutes, after which the plasma concentration decreased to reach a much lower apparent steady-state drug concentration at 420 minutes. The area under the plasma concentration-time curve (AUC) obtained after oral administration of a second ATRA dose (1.60 mg kg(-1)) was approximately 8% of the AUC obtained after a single oral dose; consistent with a time-dependent increase in the elimination of ATRA, as was observed after IV administration.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15198502      PMCID: PMC2750936          DOI: 10.1208/ps060101

Source DB:  PubMed          Journal:  AAPS PharmSci        ISSN: 1522-1059


  21 in total

1.  Time- and dose-dependent kinetics of all-trans-retinoic acid in rats after oral or intravenous administration(s).

Authors:  S el Mansouri; M Tod; M Leclerq; O Petitjean; G Perret; M Porthault
Journal:  Drug Metab Dispos       Date:  1995-02       Impact factor: 3.922

2.  Pharmacokinetic absorption plots from oral data alone or oral/intravenous data and an exact Loo-Riegelman equation.

Authors:  J G Wagner
Journal:  J Pharm Sci       Date:  1983-07       Impact factor: 3.534

Review 3.  Clinical pharmacokinetics of tretinoin.

Authors:  M B Regazzi; I Iacona; C Gervasutti; M Lazzarino; S Toma
Journal:  Clin Pharmacokinet       Date:  1997-05       Impact factor: 6.447

4.  Phase II study of a combination of cisplatin, all-trans-retinoic acid and interferon-alpha in squamous cell carcinoma: clinical results and pharmacokinetics.

Authors:  A Goncalves; J Camerlo; H Bun; G Gravis; D Genre; F Bertucci; M Resbeut; F Pech-Gourg; A Durand; D Maraninchi; P Viens
Journal:  Anticancer Res       Date:  2001 Mar-Apr       Impact factor: 2.480

Review 5.  Differentiating agents in pediatric malignancies: retinoids in neuroblastoma.

Authors:  C P Reynolds
Journal:  Curr Oncol Rep       Date:  2000-11       Impact factor: 5.075

Review 6.  Retinoid therapy of childhood cancer.

Authors:  C P Reynolds; R S Lemons
Journal:  Hematol Oncol Clin North Am       Date:  2001-10       Impact factor: 3.722

7.  Cloning of rat cytochrome P450RAI (CYP26) cDNA and regulation of its gene expression by all-trans-retinoic acid in vivo.

Authors:  Yuanping Wang; Reza Zolfaghari; A Catharine Ross
Journal:  Arch Biochem Biophys       Date:  2002-05-15       Impact factor: 4.013

Review 8.  Retinoic acid resistance in acute promyelocytic leukemia.

Authors:  R E Gallagher
Journal:  Leukemia       Date:  2002-10       Impact factor: 11.528

9.  Dose-dependent pharmacokinetics of all-trans-retinoic acid.

Authors:  P C Adamson; F M Balis; M A Smith; R F Murphy; K A Godwin; D G Poplack
Journal:  J Natl Cancer Inst       Date:  1992-09-02       Impact factor: 13.506

10.  Phase I trial of interferon alpha2b and liposome-encapsulated all-trans retinoic acid in the treatment of patients with advanced renal cell carcinoma.

Authors:  Jonathan S Goldberg; Manuel Vargas; Alyssa S Rosmarin; Matthew I Milowsky; Nicholas Papanicoloau; Lorraine J Gudas; Gary Shelton; Kevie Feit; Daniel Petrylak; David M Nanus
Journal:  Cancer       Date:  2002-09-15       Impact factor: 6.860

View more
  7 in total

1.  Physiologically Based Pharmacokinetic Model of All-trans-Retinoic Acid with Application to Cancer Populations and Drug Interactions.

Authors:  Jing Jing; Cara Nelson; Jisun Paik; Yoshiyuki Shirasaka; John K Amory; Nina Isoherranen
Journal:  J Pharmacol Exp Ther       Date:  2017-03-08       Impact factor: 4.030

2.  Oral Delivery of Particulate Transforming Growth Factor Beta 1 and All-Trans Retinoic Acid Reduces Gut Inflammation in Murine Models of Inflammatory Bowel Disease.

Authors:  Thomas F Conway; Laura Hammer; Stacia Furtado; Edith Mathiowitz; Ferdinando Nicoletti; Katia Mangano; Nejat K Egilmez; Dominick L Auci
Journal:  J Crohns Colitis       Date:  2015-05-18       Impact factor: 9.071

3.  Effect of all-trans retinoic acid on the growth of two nasopharyngeal cancer cell lines and its treatment potential in combination with cisplatin.

Authors:  Shih-Han Hung; Fei-Peng Lee; Chin-Hui Su; How Tseng
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-06-07       Impact factor: 2.503

Review 4.  Therapeutic potential of the inhibition of the retinoic acid hydroxylases CYP26A1 and CYP26B1 by xenobiotics.

Authors:  Cara H Nelson; Brian R Buttrick; Nina Isoherranen
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

5.  VN/14-1 induces ER stress and autophagy in HP-LTLC human breast cancer cells and has excellent oral pharmacokinetic profile in female Sprague Dawley rats.

Authors:  Abhijit M Godbole; Senthilmurugan Ramalingam; Vidya P Ramamurthy; Aakanksha Khandelwal; Robert D Bruno; Vijay V Upreti; Lalji K Gediya; Puranik Purushottamachar; Hannah W Mbatia; Sankar Addya; Nicholas Ambulos; Vincent C O Njar
Journal:  Eur J Pharmacol       Date:  2014-04-12       Impact factor: 4.432

6.  Molecular dynamics of retinoic acid-induced craniofacial malformations: implications for the origin of gnathostome jaws.

Authors:  Maxence Vieux-Rochas; Laurent Coen; Takahiro Sato; Yukiko Kurihara; Yorick Gitton; Ottavia Barbieri; Karine Le Blay; Giorgio Merlo; Marc Ekker; Hiroki Kurihara; Philippe Janvier; Giovanni Levi
Journal:  PLoS One       Date:  2007-06-06       Impact factor: 3.240

7.  Cod Liver Oil, but Not Retinoic Acid, Treatment Restores Bone Thickness in a Vitamin A-Deficient Rat.

Authors:  Richard C Baybutt; Joseph T Standard; Daniel Dim; Tim Quinn; Hana Hamdan; Dingbo Lin; Kyle Kunz; Zachary S Bomstein; Benjamin J Estorge; Betty Herndon; Hamid Zia; Ahmad Mansour; Manesha Lankachandra; Agostino Molteni
Journal:  Nutrients       Date:  2022-01-22       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.